NFKB1 and neoplasm: Tumor buds co-express ezrin, nuclear NfKb and L1, central tumor regions with relative lack immunoreactivity. Together with functional data supports hypothesis that L1-mediated activation of NFkB signaling is a major route of CRC tumor progression